Sg Americas Securities, LLC Fulcrum Therapeutics, Inc. Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 30,442 shares of FULC stock, worth $128,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,442
Previous 33,019
7.8%
Holding current value
$128,160
Previous $118,000
21.19%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FULC
# of Institutions
149Shares Held
51.9MCall Options Held
6.91MPut Options Held
1.89M-
Ra Capital Management, L.P. Boston, MA10.2MShares$43.1 Million0.51% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$22.1 Million2.43% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$20.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$20.1 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$13.8 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $219M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...